Castle Biosciences, Inc.CSTLNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank75
3Y CAGR+4.9%
5Y CAGR+31.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+4.9%/yr
vs +74.4%/yr prior
5Y CAGR
+31.4%/yr
Recent deceleration
Acceleration
-69.5pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$51.85M-0.4%
2024$52.04M-2.9%
2023$53.62M+19.4%
2022$44.90M+51.5%
2021$29.65M+123.6%
2020$13.26M+79.5%
2019$7.38M+52.1%
2018$4.85M+8.5%
2017$4.47M-